Wellington Management Group LLP grew its position in Amdocs Limited (NASDAQ:DOX - Free Report) by 25.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,680,422 shares of the technology company's stock after acquiring an additional 543,490 shares during the quarter. Wellington Management Group LLP owned about 2.37% of Amdocs worth $228,211,000 at the end of the most recent reporting period.
A number of other hedge funds have also modified their holdings of the business. Raymond James Financial Inc. purchased a new stake in Amdocs during the 4th quarter valued at approximately $44,494,000. Vanguard Group Inc. lifted its holdings in shares of Amdocs by 16.1% during the fourth quarter. Vanguard Group Inc. now owns 3,074,424 shares of the technology company's stock worth $261,756,000 after purchasing an additional 426,035 shares during the period. Pzena Investment Management LLC grew its position in Amdocs by 4.3% in the 4th quarter. Pzena Investment Management LLC now owns 6,634,549 shares of the technology company's stock valued at $564,866,000 after buying an additional 270,810 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Amdocs by 1,207.3% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 271,701 shares of the technology company's stock valued at $23,768,000 after buying an additional 250,918 shares during the period. Finally, Arrowstreet Capital Limited Partnership raised its position in Amdocs by 30.0% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 827,317 shares of the technology company's stock worth $70,438,000 after buying an additional 191,013 shares during the last quarter. 92.02% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Separately, StockNews.com lowered shares of Amdocs from a "strong-buy" rating to a "buy" rating in a research note on Friday, February 28th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $101.20.
Get Our Latest Report on Amdocs
Amdocs Price Performance
DOX traded down $1.62 on Monday, hitting $82.08. 1,373,916 shares of the company were exchanged, compared to its average volume of 693,383. Amdocs Limited has a fifty-two week low of $74.41 and a fifty-two week high of $93.34. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.20 and a current ratio of 1.16. The firm has a market capitalization of $9.27 billion, a P/E ratio of 19.04, a price-to-earnings-growth ratio of 1.47 and a beta of 0.59. The business's fifty day moving average is $88.19 and its 200 day moving average is $87.42.
Amdocs (NASDAQ:DOX - Get Free Report) last released its quarterly earnings results on Tuesday, February 4th. The technology company reported $1.45 earnings per share for the quarter, missing analysts' consensus estimates of $1.64 by ($0.19). Amdocs had a return on equity of 18.89% and a net margin of 10.19%. As a group, sell-side analysts anticipate that Amdocs Limited will post 6.21 EPS for the current year.
Amdocs Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Monday, March 31st will be issued a dividend of $0.527 per share. This is an increase from Amdocs's previous quarterly dividend of $0.48. This represents a $2.11 annualized dividend and a yield of 2.57%. The ex-dividend date of this dividend is Monday, March 31st. Amdocs's dividend payout ratio (DPR) is 48.72%.
About Amdocs
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Featured Stories

Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.